Factory Supply Cefotaxime Sodium Pharmaceutical Cefotaxime Sodium Raw Material Powder Cefotaxime Sodium

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Model NO.: Dsung-Cefotaxime Sodium
• Product Name: Cefotaxime Sodium
• Name: Cefotaxime Sodium Powder
• Appearance: White Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Antibiotics
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 64485-93-4
• Molecular Formula: C16h16n5nao7s2
• MW: 477.44700
• Melting Point: 162-163 C(Lit.)
• Density: 1.8 g/cm3
• Psa: 229.88000
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 500kg/Month

Product Description

Factory Supply Cefotaxime Sodium Pharmaceutical Cefotaxime Sodium Raw Material Powder Cefotaxime Sodium

 

Product Description

Product Details

Product Name	Cefotaxime Sodium
CAS No.	64485-93-4
Purity	99%
MW	477.44700
Appearance and shape	White powder

Cefotaxime is a third-generation cephalosporin and is a broad-spectrum antibiotic. The effect on Gram-negative bacilli is significantly better than that of the first and second-generation cephalosporins, especially against influenza bacillus, Escherichia coli, Enterobacter, Citrobacter, Serratia, Klebsiella and β. - The action of lactamase-resistant Escherichia coli is stronger than that of cefoperazone, and the effect of Haemophilus producing penicillinase is the strongest. Cefotaxime treatment of patients with hematological malignancies has the best clinical response and long duration of bactericidal action, but the bactericidal effect on Pseudomonas aeruginosa and Enterobacter cloacae is poor.

Application & Function

1. Lower respiratory tract infections (such as pneumonia).
2. Genitourinary infections (including urinary tract infections, metritis, prostatitis, gonorrhea, etc.).
3. Intraperitoneal infections (such as peritonitis, biliary tract, etc.).
4. Bone, joint, skin and soft tissue infections.
5. Prevention of surgical infections.
6. ENT infection.
7. Other serious infections, such as acute suppurative meningitis (especially infantile meningitis), bacterial endocarditis, sepsis, etc.

Specification